CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
High ImpactOriginal article

Curium to acquire Lantheus in all-cash deal worth up to $8bn

Positive
AI Analysis

Summary

CapVest Partners-backed Curium has agreed to acquire Lantheus Holdings in an all-cash transaction valued at up to $8 billion, consolidating two major players in the radiopharmaceutical sector.

Importance:8/10
Sentiment:
0.60
M&Aacquisitionradiopharmaceuticalsall-cash deal
Related Companies

Read the original article

Published by Pharmaceutical Technology on August 4, 2026 8:43 AM

Read Original